Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
NASDAQ: $CVKD BIG OPPORTUNITY
2025 Projected Revenue: $6.3 million, driven by potential initial commercialization of tecarfarin.
2026 Projected Revenue: $16.8 million, reflecting expected market adoption and growth?
NASDAQ: $CVKD
2025 Projected Revenue: $6.3 million, driven by potential initial commercialization of tecarfarin.
2026 Projected Revenue: $16.8 million, reflecting expected market adoption and growth?
NASDAQ: $CVKD BIG WAVE SOON, STRONG💪💪
2025 Projected Revenue: $6.3 million, driven by potential initial commercialization of tecarfarin.
2026 Projected Revenue: $16.8 million,reflecting expected market adoption and growth?
NASDAQ: $CVKD
Hc Wainwright raises Cadrenal Therapeutics price target to $32 from $3
Buy
Innovative Drug & Partnership: Tecarfarin, developed with Abbott, targets a $2B U.S. market for blood thinners.
NASDAQ: $CVKD
Cadrenal Therapeutics Wins "Anticoagulation Therapy Company of the Year"
$CVKD
-Hc Wainwright raises Cadrenal Therapeutics price target $32
Buy
NASDAQ: $CVKD
Cadrenal Therapeutics Named "Anticoagulation Therapy Company of the Year"
$CVKD-Hc Wainwright raises Cadrenal Therapeutics price target to $32 from $3
Buy
Breaking NEWS:🚨
Cadrenal Therapeutics Wins "Anticoagulation Therapy Company of the Year"
Innovation: Tecarfarin minimizes drug interactions, improves stability, and suits patients with kidney impairment.
NASDAQ: $CVKD Upcoming Catalysts: With trial results and potential FDA approval on the horizon, CVKD is positioned for substantial growth, presenting a strategic opportunity for investors in the biotech space.
NASDAQ: $CVKD Targeting a $2 billion US market and addresses a critical unmet medical need in cardiovascular care during a global health crisis
NASDAQ: $CVKD Cadrenal is collaborating with Abbott on Tecarfarin, a novel blood thinner targeting a $2 billion U.S. market.
Hc Wainwright raises Cadrenal Therapeutics price target to $32 from $3
All the makings of a very big drug with longevity to match. All IMO
The below was reported at the September 16, 2024 update.
“The final protocol will be announced following discussions with the FDA in fall 2024”
It’s fall 2024. Y’all ready?
This thing finally moving huh $CVKD
$CVKD BIG NEWS : New Blood Thinner Ready for Phase 3; Initiating Coverage of Cadrenal
Therapeutics, Inc
Zack Smallcap Research report - https://s27.q4cdn.com/906368049/files/News/2024/Zacks_SCR_Research_09162024_CVKD_Bautz.pdf
With all do respect...this one turned out nice...ty.
Excellent move, much more to come $CVKD
Heart disease $200 Billion problem and they should have a very nice niche of it with their upcoming treatment. Let’s see gimme $100
I dont understand why this is dropping. I am going to hold though because the price is predicted to get to 52.00.
$CVKD Chart looks ready to move higher imo https://schrts.co/hfdruFjZ
$CVKD Research Report must Read - https://bigstocks.com/cadrenal-therapeutics/
$CVKD 1 Month bullish chart https://schrts.co/ijBMJKCK
$CVKD Strong buy from #tradingview https://www.tradingview.com/symbols/NASDAQ-CVKD/technicals/
$CVKD Cadrenal Therapeutics Announces Upcoming Type-B FDA Meeting in September to Discuss Tecarfarin Trial in LVAD Patients https://finance.yahoo.com/news/cadrenal-therapeutics-announces-upcoming-type-130000800.html?soc_src=social-sh&soc_trk=tw&tsrc=twtr via
@YahooFinance
$CVKD Volume precedes price action, following trend pattern could see reversal any time any days imo!
https://schrts.co/hGXgHbiy
Fine as wine.....
CVKD 8 BUCKS, LETS SEE 9.00
CVKD...WE SEE 8 BUCKS TODAY OR TOMORROW
here comes 8 dolla....lmao
Do not listen to this guy. Here is his last recco which is now under $2.00
TrendTrade2016
Re: None
Friday, August 02, 2024 8:34:21 AM
Post#
4
of 13
VSEE HERE COMES 7 BUCKS
CVKD 8 BUCKS COMING TO TOWN
CVKD...LETS SEE 8 DOLLA
CVKD...THERE SHE GOES
CVKD...POST SPLIT BEASTING...1 MILLY FLOT
its trying to inch up now, lets ….
….
see what happens here.
Green time run here, partnerships and approval coming in this order imo!
Followers
|
10
|
Posters
|
|
Posts (Today)
|
0
|
Posts (Total)
|
113
|
Created
|
01/20/23
|
Type
|
Free
|
Moderators |
Volume | |
Day Range: | |
Bid Price | |
Ask Price | |
Last Trade Time: |